Tracker › Companies › Gilead Sciences, Inc.
5 No sign of it. We found no public evidence tying Gilead Sciences, Inc.'s cuts to AI.
Every tracked 2026 layoff at Gilead Sciences, Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 5/100 (Minimal) · 80% interval 4–6 · evidence grade D · CA, MD · Biotechnology
Stated reason: Integration cuts after Gilead's $7.8 billion acquisition of Arcellx, including most of Arcellx's Redwood City and Rockville staff.
Why 5: Merger / acquisition integration · Drivers: industry AI exposure +0.6, contrary evidence −0.2
Evidence: SEC filing, state WARN notice, major-outlet report. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.894, industry exposure 0.858, AI investment 0.0, contrary evidence 0.15 · typical Technology roles (no roles named)
Headcount basis: WARN (sum of state notices; company-wide total not disclosed) · WARN: 243 workers at 3 site notice(s)
AI score 5/100 (Minimal) · 80% interval 4–6 · evidence grade D · CA · Unknown
Stated reason: No reason published in the state WARN data
Why 5: No stated reason · Drivers: industry AI exposure +0.3
Evidence: state WARN notice. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.5, industry exposure 0.502, AI investment 0.0, contrary evidence 0.0 · typical Other / Unknown roles (no roles named)
Headcount basis: WARN (sum of state notices) · WARN: 34 workers at 1 site notice(s)
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Technology layoffs we track.
